Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21
Cheryl Cohen, Jackie Kleynhans, Anne von Gottberg, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 821-834
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e229317-e229317
Open Access | Times Cited: 203
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Hannah C. Lewis, Harriet Ware, Mairead Whelan, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008793-e008793
Open Access | Times Cited: 119
Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study
Zhiyuan Chen, Xiaowei Deng, Li‐Qun Fang, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 29, pp. 100592-100592
Open Access | Times Cited: 100
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 74
Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic
Ana Rúbia Guedes, Maura Salaroli de Oliveira, Bruno de Melo Tavares, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 51
A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022
Xinhua Chen, Xuemei Yan, Kaiyuan Sun, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2800-2807
Open Access | Times Cited: 64
SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts
Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 659
Open Access | Times Cited: 51
Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa
Nicole Wolter, Waasila Jassat, Anne von Gottberg, et al.
The Lancet (2022) Vol. 400, Iss. 10346, pp. 93-96
Open Access | Times Cited: 48
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 29
COVID-19 infection, reinfection, and the transition to endemicity
Cheryl Cohen, Juliet R. C. Pulliam
The Lancet (2023) Vol. 401, Iss. 10379, pp. 798-800
Open Access | Times Cited: 27
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
Joyeuse Ukwishaka, Yves Ndayishimiye, Esmeralda Destine, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Omicron variant evolution on vaccines and monoclonal antibodies
Michela Sabbatucci, Antonio Vitiello, Salvatore Clemente, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1779-1788
Open Access | Times Cited: 25
Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018
Cheryl Cohen, Jackie Kleynhans, Jocelyn Moyes, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2805-2812
Closed Access | Times Cited: 8
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy Russell, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0294897-e0294897
Open Access | Times Cited: 7
A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Yinghong Xiao, Peter V. Lidsky, Yuta Shirogane, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6037-6051.e14
Open Access | Times Cited: 54
Natural and hybrid immunity following four COVID-19 waves: A prospective cohort study of mothers in South Africa
Heather J. Zar, Rae MacGinty, Lesley Workman, et al.
EClinicalMedicine (2022) Vol. 53, pp. 101655-101655
Open Access | Times Cited: 34
Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations
Lily E. Cohen, David Spiro, Cécile Viboud
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010591-e1010591
Open Access | Times Cited: 31
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
Idowu B. Olawoye, Paul E. Oluniyi, Judith U. Oguzie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica
Kaiyuan Sun, Viviana Loría, Amada Aparicio, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
Meagan E. Deming, Elizabeth R. Brown, Monica A. McArthur, et al.
The Lancet Microbe (2025), pp. 100984-100984
Open Access
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
Chaochao Qiu, Xiao-Qing Lin, Qiang Zhang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top